P2RY1 and renal cell carcinoma: For example, in a renal cell carcinoma model, Zhai et al. indicated that lncRNA-SARCC could suppress renal cell carcinoma (RCC) progression by altering androgen receptor (AR)/miRNA-143-3p signals (18).